Shares of AnaptysBio Inc. are up nearly 24% year-to-date, way ahead of the iShares NASDAQ Biotechnology Index, which has gained just 2.77% during the same time frame. Given the fact that AnaptysBio has couple of announcements up its sleeve, it's worth keeping an eye on this stock.
from RTT - Biotech http://ift.tt/2EKc9Wf
via IFTTT
No comments:
Post a Comment